Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(9%)
Results Posted
14%(1 trials)

Phase Distribution

Ph not_applicable
4
36%
Ph phase_4
1
9%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(7)
Other(2)

Detailed Status

Completed7
unknown2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (20.0%)
N/A4 (80.0%)

Trials by Status

completed764%
recruiting19%
not_yet_recruiting19%
unknown218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11